Summary
31 of 36 elderly mainly confused hospitalized patients (69–98 years) taking temazepam 10 mgs nocte for more than one month completed a double blind randomised placebo controlled trial comparing abrupt versus gradual withdrawal of temazepam. Hours of sleep were recorded for all patients during a 7 day baseline period while taking temazepam l0 mg nocte. Then the abrupt withdrawal (AW) group (n=15) received placebo for 10 nights and the gradual withdrawal (GW) group (n=16) received temazepam 5 mg for the first 4 nights, 2 mg for the next 4 nights and placebo for the last 2 nights. There was no significant difference in mean hours of nightly sleep during the baseline period between the AW group (5.9 ± 1.1 SD) and GW group (5.8 ±1.1 SD) and between the baseline and withdrawal periods in each group (withdrawal periods, AW 5.6 ± 1.2, GW 5.6 ±1.0). There was no rebound insomnia when temazepam was withdrawn either abruptly or gradually in long-term hospitalised elderly patients and may not be effective as a long-term hypnotic. Address for Correspondence:
Similar content being viewed by others
References
Williamson, J., Chopin, J. M. Adverse reactions to prescribed drugs in the elderly: A multicentre investigation. Age and Ageing 1980; 9: 73–80.
Greenblatt, D. J., Allen, M. D. Toxicity of nitrazepam in the elderly: A report from the Boston Collaborative Drug Surveillance Program. Br.J.Clin. Pharmac 1978:5:407–413.
Boston Collaborative Drug Surveillance ProgramClinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. N. Engl. J. Med. 1973: 288: 277–280.
Kales, A., Bixler, E.O., Soldatos, C. R., Vela-Bueno, A., Jacoby, J. A., Kales, J. D. Quazelpam and temazepam: Effects of short and intermediate-term use and withdrawal. Clin. Pharmacol Ther. 1986; 39: 345–352.
Kales, A., Kales, J. D. Sleep laboratory studies of hypnotic drugs: Efficacy and withdrawal effects. J. Clin Psychopharmacology 1983; 3: 140–150.
Kales, A. Bixler, E. O., Bela-Bueno, A., Soldatos, C. R., Manfredi, R. L. Alprazolam: Effects on sleep and withdrawal phenomena. J. Clin. Pharmacol 1987: 27: 508–515.
Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., Shader, R. I. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. New Eng. J.Med. 1988: 317: 722–728.
Kales,J.D., Kales,A., Soldatos,C.R. Quazepam: Sleep laboratory studies of effectiveness and withdrawal. Clin. Neuropharmacology 1985: 8: Suppl. 1, S55-S62.
Committee on Safety of Medicines. Benzodiazepines, dependence and withdrawal symptoms. January 1988: No. 21.
Busto, U, Seller, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M, Sykora, K. Withdrawal reaction after longterm therapeutic use of benzodiazepines. New Eng. J. Med. 1986; 315: 854–859.
Mollma, T. A., Uhde, T. W. Withdrawal syndrome with gradual tapering of alprazolam. Am. J. Psychiatry 1986: 143: 1464–1466.
Mant, A. Wodak, A., Day, R. Benzodiazepine dependence: Strategies for prevention and withdrawal. Current Therapeutics 1987: Feb. 59–79.
Foy, A., Drinkwater, V., March, S.,Mearrick, P. Confusion after admission to hospital in elderly patients using benzodiazepines. Br. Med. J. 1988: 293: 1072.
Quershi, K. N., Hodkinson, H. M. Evaluation of a ten question menial test in the institution-alised patient. Age and Ageing 1974:3:152–157.
Smith, R. B., Divoll, M. Gillespie, W. R.,Greenblatt, D. J. Effect of subject age and gender on the pharmokinetics or oral triazolam and temazepam. J. Clin. Psychopharmacology. 1983: 3: 172–176
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tham, T.C.K., Brown, H. & McA Taggart, H. Temazepam withdrawal in elderly hospitalized patients: a double blind randomised trial comparing abrupt versus gradual withdrawal. I.J.M.S. 158, 294–296 (1989). https://doi.org/10.1007/BF02942077
Issue Date:
DOI: https://doi.org/10.1007/BF02942077